Evaluation of Tryptophan/Kynurenine Pathway Relevance With Immune System Biomarkers of Low Energy Trauma Hip Fractures in Osteoporotic Patients

Overview

Journal Arch Rheumatol

Specialty Rheumatology

Date 2018 Oct 31

PMID 30375548

Citations 5

Authors

Ercan Dincel

Yesim Ozkan

Murat Sukuroglu

Hakan Ozsoy

Aylin Sepici Dincel

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aims to evaluate tryptophan degradation and clarify whether altered levels of kynurenine and tryptophan (Kyn/Trp) ratio could be correlated to osteoporotic hip fractures via immune system.

Patients And Methods: The study included 60 patients with osteoporotic hip fracture (20 males, 40 females, mean age 76.6±6.9 years; range 59 to 95 years). Patients were divided into two as patients with collum femoris fractures (group 1; n=23) and intertrochanteric fractures (group 2; n=37). Fifteen healthy subjects without any fracture were selected as control group (group 3; 3 males, 12 females; mean age 69.7±8.4; range 60 to 86 years). All fractures were simple falls due to low energy trauma. Bone mineral density measurements were performed with Lunar dual energy X-ray absorptiometry. Kyn/Trp levels were measured by high performance liquid chromatography. Interleukin (IL)-6 and IL-1 beta levels were measured with solid-phase sandwich enzyme-linked immunosorbent assay.

Results: All bone mineral density values were in agreement for osteoporosis and there was no significant difference between the two groups. Higher Kyn/Trp ratios were observed in groups 1 and 2 compared to group 3. This difference was more significant in group 1 (p=0.0001) than that in group 2 (p=0.048). Also, group 1 had significantly higher Kyn/Trp ratio than group 2 (p=0.011). There were significantly higher IL-6 and lower IL-1 beta levels both in groups 1 and 2 compared to group 3 (p=0.0001). There was no significant difference between group 1 and group 2 in terms of IL-6 and IL-1 beta levels. There was positive correlation with Kyn/Trp ratio (r=0.581, p=0.004) in group 2. Also, significant correlation was detected between IL-6 and IL-1 beta levels in the same group (r=0.665, p=0.036).

Conclusion: Both increased degradation of tryptophan and ratio of Kyn/Trp indicate the relationship of immune activation with bone healing.

Citing Articles

Differentially expressed genes and miRNAs in female osteoporosis patients.

Zhou H, Jiang J, Chen X, Zhang Z Medicine (Baltimore). 2022; 101(28):e29856.

PMID: 35839011 PMC: 11132388. DOI: 10.1097/MD.0000000000029856.

Cross-reaction between mouse and rat immunoglobulin G: does it matter in sandwich ELISA?.

Nadeem R, Barakat A, Bahgat M J Genet Eng Biotechnol. 2021; 19(1):119.

PMID: 34403025 PMC: 8369443. DOI: 10.1186/s43141-021-00222-2.

Metabolomics in Bone Research.

Fan J, Jahed V, Klavins K Metabolites. 2021; 11(7).

PMID: 34357328 PMC: 8303949. DOI: 10.3390/metabo11070434.

Elmansi A, Hussein K, Herrero S, Periyasamy-Thandavan S, Aguilar-Perez A, Kondrikova G Bone Rep. 2020; 12:100270.

PMID: 32395570 PMC: 7210406. DOI: 10.1016/j.bonr.2020.100270.

Chronic dietary supplementation with kynurenic acid, a neuroactive metabolite of tryptophan, decreased body weight without negative influence on densitometry and mandibular bone biomechanical endurance in young rats.

Tomaszewska E, Muszynski S, Kuc D, Dobrowolski P, Lamorski K, Smolinska K PLoS One. 2019; 14(12):e0226205.

PMID: 31809528 PMC: 6897417. DOI: 10.1371/journal.pone.0226205.

References

Apalset E, Gjesdal C, Ueland P, Oyen J, Meyer K, Midttun O . Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study. Osteoporos Int. 2014; 25(8):2067-75. PMC: 4099528. DOI: 10.1007/s00198-014-2720-7. View

Brown R, Ozaki Y, Datta S, Borden E, Sondel P, Malone D . Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol. 1991; 294:425-35. DOI: 10.1007/978-1-4684-5952-4_39. View

Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, Petrangeli M . High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med. 2006; 166(22):2495-501. DOI: 10.1001/archinte.166.22.2495. View

Barbour K, Boudreau R, Danielson M, Youk A, Wactawski-Wende J, Greep N . Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res. 2012; 27(5):1167-76. PMC: 3361578. DOI: 10.1002/jbmr.1559. View

Chen R, Chen T, Chiu W, Chang C . Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J Orthop Res. 2005; 23(2):462-8. DOI: 10.1016/j.orthres.2004.08.011. View

Lorentzon M, Landin K, Mellstrom D, Ohlsson C . Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men. J Bone Miner Res. 2006; 21(12):1871-8. DOI: 10.1359/jbmr.060814. View

Fox K, Magaziner J, Hebel J, Kenzora J, Kashner T . Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae. J Gerontol A Biol Sci Med Sci. 2000; 54(12):M635-40. DOI: 10.1093/gerona/54.12.m635. View

Ishii S, Cauley J, Greendale G, Crandall C, Danielson M, Ouchi Y . C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2013; 28(7):1688-98. PMC: 3880424. DOI: 10.1002/jbmr.1915. View

Fatokun A, Hunt N, Ball H . Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids. 2013; 45(6):1319-29. DOI: 10.1007/s00726-013-1602-1. View

10.

Munn D, Mellor A . Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol. 2012; 34(3):137-43. PMC: 3594632. DOI: 10.1016/j.it.2012.10.001. View

11.

Heaney R . Nutritional factors in osteoporosis. Annu Rev Nutr. 1993; 13:287-316. DOI: 10.1146/annurev.nu.13.070193.001443. View

12.

Ozkan Y, Sukuroglu M, Tulmac M, Kisa U, Simsek B . Relation of kynurenine/tryptophan with immune and inflammatory markers in coronary artery disease. Clin Lab. 2014; 60(3):391-6. DOI: 10.7754/clin.lab.2013.121204. View

13.

Ploder M, Spittler A, Schroecksnadel K, Neurauter G, Pelinka L, Roth E . Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors. Clin Sci (Lond). 2008; 116(7):593-8. DOI: 10.1042/CS20080319. View

14.

Dincel V, Sengelen M, Sepici V, Cavusoglu T, Sepici B . The association of proximal femur geometry with hip fracture risk. Clin Anat. 2008; 21(6):575-80. DOI: 10.1002/ca.20680. View

15.

Casado F, Singh K, Gasiewicz T . Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration. Mol Pharmacol. 2011; 80(4):673-82. PMC: 3187533. DOI: 10.1124/mol.111.071381. View

16.

Lorenzo J, Horowitz M, Choi Y . Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008; 29(4):403-40. PMC: 2528852. DOI: 10.1210/er.2007-0038. View

17.

Ozkan Y, Mete G, Sepici-Dincel A, Sepici V, Simsek B . Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients. Clin Rheumatol. 2011; 31(1):29-34. DOI: 10.1007/s10067-011-1767-5. View

18.

Dincel V, Sepici-Dincel A . The importance and the differences of bone morphogenetic proteins for osteoporotic hip fractures. Acta Orthop Belg. 2014; 80(2):216-21. View

19.

Zhang X, He Y, Ding M . Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(16-17):1678-82. DOI: 10.1016/j.jchromb.2009.04.013. View

20.

Bonjour J, Schurch M, Rizzoli R . Nutritional aspects of hip fractures. Bone. 1996; 18(3 Suppl):139S-144S. DOI: 10.1016/8756-3282(95)00494-7. View